866-997-4948(US-Canada Toll Free)

AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2018 Update

Published By :

GlobalData

Published Date : Sep 2018

Category :

Medical Equipments

No. of Pages : 72 Pages

Summary

AngioDynamics Inc (AngioDynamics) is a provider of minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. It has operations in North America, Europe and Asia. AngioDynamics is headquartered in New York, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AngioDynamics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
AngioDynamics Inc Company Overview 7
AngioDynamics Inc Company Snapshot 7
AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview 7
AngioDynamics Inc Pipeline Analysis Overview 10
Business Description 10
AngioDynamics Inc - Key Facts 10
AngioDynamics Inc - Major Products and Services 11
AngioDynamics Inc Pipeline Products by Development Stage 15
AngioDynamics Inc Ongoing Clinical Trials by Trial Status 17
AngioDynamics Inc Pipeline Products Overview 20
AngioVac Line Extension 20
AngioVac Line Extension Product Overview 20
AngioVac Low Profile Catheter 21
AngioVac Low Profile Catheter Product Overview 21
Automated Fluid Management System 22
Automated Fluid Management System Product Overview 22
BioFlo PICC Line Extension 23
BioFlo PICC Line Extension Product Overview 23
BioFlo Portline Line Extension 24
BioFlo Portline Line Extension Product Overview 24
Celerity PICC Tip Confirmation System With Navigation 25
Celerity PICC Tip Confirmation System With Navigation Product Overview 25
Coronary Angio Catheter 26
Coronary Angio Catheter Product Overview 26
FireFly Tip Location 27
FireFly Tip Location Product Overview 27
Inflation Device 28
Inflation Device Product Overview 28
Mechanical Thrombectomy Device 29
Mechanical Thrombectomy Device Product Overview 29
NanoKnife 3.0 30
NanoKnife 3.0 Product Overview 30
NanoKnife 3.0 Clinical Trial 31
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma 32
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma Product Overview 32
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma Clinical Trial 33
NanoKnife System - Pancreatic Cancer 36
NanoKnife System - Pancreatic Cancer Product Overview 36
NanoKnife System - Pancreatic Cancer Clinical Trial 37
NanoKnife System - Prostate Cancer 40
NanoKnife System - Prostate Cancer Product Overview 40
NanoKnife System - Prostate Cancer Clinical Trial 41
Next Gen Tumescent Delivery Device 43
Next Gen Tumescent Delivery Device Product Overview 43
Next Generation BioFlo PICC 44
Next Generation BioFlo PICC Product Overview 44
Next Generation BioFlo Port 45
Next Generation BioFlo Port Product Overview 45
Next Generation Dialysis Device 46
Next Generation Dialysis Device Product Overview 46
Next Generation Laser 47
Next Generation Laser Product Overview 47
Next Generation Radio Frequency Ablation System 48
Next Generation Radio Frequency Ablation System Product Overview 48
Non-Thermal Vein Ablation Device 49
Non-Thermal Vein Ablation Device Product Overview 49
Peripheral Vascular Drainage Line Extension 50
Peripheral Vascular Drainage Line Extension Product Overview 50
Smart Port - Dual 51
Smart Port - Dual Product Overview 51
Thrombus Management Device 52
Thrombus Management Device Product Overview 52
Ultrasound-Assisted Thrombectomy System 53
Ultrasound-Assisted Thrombectomy System Product Overview 53
AngioDynamics Inc - Key Competitors 54
AngioDynamics Inc - Key Employees 55
AngioDynamics Inc - Key Employee Biographies 56
AngioDynamics Inc - Locations And Subsidiaries 57
Head Office 57
Other Locations & Subsidiaries 57
Recent Developments 59
AngioDynamics Inc, Recent Developments 59
Jul 11, 2018: AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results 59
Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 60
Jan 24, 2018: AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System for the Treatment of Stage III Pancreatic Cancer 61
Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 61
Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 62
Sep 14, 2017: Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open 63
Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 64
Jun 07, 2017: AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System 66
May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 66
Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 67
Appendix 69
Methodology 69
About GlobalData 72
Contact Us 72
Disclaimer 72

List of Tables
AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview 7
AngioDynamics Inc Pipeline Products by Equipment Type 8
AngioDynamics Inc Pipeline Products by Indication 9
AngioDynamics Inc Ongoing Clinical Trials by Trial Status 9
AngioDynamics Inc, Key Facts 10
AngioDynamics Inc, Major Products and Services 11
AngioDynamics Inc Number of Pipeline Products by Development Stage 15
AngioDynamics Inc Pipeline Products Summary by Development Stage 16
AngioDynamics Inc Ongoing Clinical Trials by Trial Status 17
AngioDynamics Inc Ongoing Clinical Trials Summary 18
AngioVac Line Extension - Product Status 20
AngioVac Line Extension - Product Description 20
AngioVac Low Profile Catheter - Product Status 21
AngioVac Low Profile Catheter - Product Description 21
Automated Fluid Management System - Product Status 22
Automated Fluid Management System - Product Description 22
BioFlo PICC Line Extension - Product Status 23
BioFlo PICC Line Extension - Product Description 23
BioFlo Portline Line Extension - Product Status 24
BioFlo Portline Line Extension - Product Description 24
Celerity PICC Tip Confirmation System With Navigation - Product Status 25
Celerity PICC Tip Confirmation System With Navigation - Product Description 25
Coronary Angio Catheter - Product Status 26
Coronary Angio Catheter - Product Description 26
FireFly Tip Location - Product Status 27
FireFly Tip Location - Product Description 27
Inflation Device - Product Status 28
Inflation Device - Product Description 28
Mechanical Thrombectomy Device - Product Status 29
Mechanical Thrombectomy Device - Product Description 29
NanoKnife 3.0 - Product Status 30
NanoKnife 3.0 - Product Description 30
NanoKnife 3.0 - The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses 31
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status 32
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description 32
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder 33
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers 33
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial: COLDFIRE-2 Study 34
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer 34
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome 35
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE) 35
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial 35
NanoKnife System - Pancreatic Cancer - Product Status 36
NanoKnife System - Pancreatic Cancer - Product Description 36
NanoKnife System - Pancreatic Cancer - A Clinical Research about Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer 37
NanoKnife System - Pancreatic Cancer - A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas 37
NanoKnife System - Pancreatic Cancer - Assessing Optimal Treatment Settings for the Ablation of Locally Advanced Pancreatic Cancer with CT-guided Percutaneous Irreversible Electroporation (ANTILOPE): A Randomized Feasibility Study 37
NanoKnife System - Pancreatic Cancer - Crossatlantic Randomized Controlled Trial Comparing Outcome in Survival after Systemic Plus Focal Therapy for Inoperable Pancreatic Carcinoma: Radiotherapy Versus Irreversible Electroporation: CROSSFIRE Trial 38
NanoKnife System - Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study 38
NanoKnife System - Pancreatic Cancer - Impact of Irreversible Electroporation on Quality of Life for Patients with Locally Advanced Pancreatic Cancer 38
NanoKnife System - Pancreatic Cancer - Interest of Irreversible Electroporation in the Treatment of Pancreatic Adenocarcinoma 39
NanoKnife System - Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer 39
NanoKnife System - Pancreatic Cancer - Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial 39
NanoKnife System - Prostate Cancer - Product Status 40
NanoKnife System - Prostate Cancer - Product Description 40
NanoKnife System - Prostate Cancer - Efficacy and Safety Assessment of Nanoknife (AngyoDynamics, USA) for Irreversible Electroporation (IRE) of Localized Prostate Cancer 41
NanoKnife System - Prostate Cancer - Focal Irreversible Electroporation as Salvage Treatment in Radio-recurrent Prostate Cancer: A Prospective Multicenter Pilot Study 41
NanoKnife System - Prostate Cancer - Irreversible Electroporation (IRE) for Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial 41
NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer 42
NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety 42
Next Gen Tumescent Delivery Device - Product Status 43
Next Gen Tumescent Delivery Device - Product Description 43
Next Generation BioFlo PICC - Product Status 44
Next Generation BioFlo PICC - Product Description 44
Next Generation BioFlo Port - Product Status 45
Next Generation BioFlo Port - Product Description 45
Next Generation Dialysis Device - Product Status 46
Next Generation Dialysis Device - Product Description 46
Next Generation Laser - Product Status 47
Next Generation Laser - Product Description 47
Next Generation Radio Frequency Ablation System - Product Status 48
Next Generation Radio Frequency Ablation System - Product Description 48
Non-Thermal Vein Ablation Device - Product Status 49
Non-Thermal Vein Ablation Device - Product Description 49
Peripheral Vascular Drainage Line Extension - Product Status 50
Peripheral Vascular Drainage Line Extension - Product Description 50
Smart Port - Dual - Product Status 51
Smart Port - Dual - Product Description 51
Thrombus Management Device - Product Status 52
Thrombus Management Device - Product Description 52
Ultrasound-Assisted Thrombectomy System - Product Status 53
Ultrasound-Assisted Thrombectomy System - Product Description 53
AngioDynamics Inc, Key Employees 55
AngioDynamics Inc, Key Employee Biographies 56
AngioDynamics Inc, Other Locations 57
AngioDynamics Inc, Subsidiaries 57
Glossary 71

List of Figures
AngioDynamics Inc Pipeline Products by Equipment Type 8
AngioDynamics Inc Pipeline Products by Development Stage 15
AngioDynamics Inc Ongoing Clinical Trials by Trial Status 17

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *